Predicting Success in Regulatory Approval From Phase I Results

gan Malik, Laeeq, Mejia, Alex, Parsons, Helen, Ehler, Benjamin, Mahalingam, Devalingam, Brenner, Andrew, Sarantopoulos, John, Weitman, Steven
Cyhoeddwyd yn Cancer Chemother Pharmacol (2014)

Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials

gan Patel, Sukeshi R., Karnad, Anand B., Ketchum, Norma S., Pollock, Brad H., Sarantopoulos, John, Weitman, Steven, Mahalingam, Devalingam
Cyhoeddwyd 2014

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians

gan Ramirez, Amelie G., Chalela, Patricia, Suarez, Lucina, Muñoz, Edgar, Pollock, Brad H., Weitman, Steven D., Gallion, Kipling J.
Cyhoeddwyd 2012

Safety and pharmacodynamics of the PDE4 inhibitor roflumilast in advanced B cell malignancies

gan Kelly, Kevin, Mejia, Alex, Suhasini, Avvaru, Lin, An-Ping, Kuhn, John, Karnad, Anand B., Weitman, Steven, Aguiar, Ricardo C. T.
Cyhoeddwyd yn Clin Cancer Res (2016)

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives

gan Chalela, Patricia, Suarez, Lucina, Muñoz, Edgar, Gallion, Kipling J., Pollock, Brad H., Weitman, Steven D., Karnad, Anand, Ramirez, Amelie G.
Cyhoeddwyd 2014

Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-esca...

gan Stathis, Anastasios, Flinn, Ian W., Madan, Sumit, Maddocks, Kami, Freedman, Arnold, Weitman, Steven, Zucca, Emanuele, Munteanu, Mihaela C., Lia Palomba, M.
Cyhoeddwyd yn Invest New Drugs (2018)

Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal im...

gan Kelly, Kevin R., Gabrail, Nashat, Weitman, Steven, Sarantopoulos, John, Olszanski, Anthony J., Edenfield, William, Venitz, Jurgen, Reddy, Guru, Yang, Allen, Hasal, Steven J., Lockhart, A. Craig
Cyhoeddwyd yn Cancer Chemother Pharmacol (2016)

Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type 2 Diabetes

gan Wang, Chen-Pin, Lehman, Donna M., Lam, Yui-Wing F., Kuhn, John G., Mahalingam, Devalingam, Weitman, Steven, Lorenzo, Carlos, Downs, John R., Stuart, Elizabeth A, Hernandez, Javier, Thompson, Ian M., Ramirez, Amelie G.
Cyhoeddwyd yn Cancer Prev Res (Phila) (2016)

Combined venetoclax and alvocidib in acute myeloid leukemia

gan Bogenberger, James, Whatcott, Clifford, Hansen, Nanna, Delman, Devora, Shi, Chang-Xin, Kim, Wontak, Haws, Hillary, Soh, Katherine, Lee, Ye Sol, Peterson, Peter, Siddiqui-Jain, Adam, Weitman, Steven, Stewart, Keith, Bearss, David, Mesa, Ruben, Warner, Steven, Tibes, Raoul
Cyhoeddwyd yn Oncotarget (2017)

Single-cell Analysis of Circulating Tumor Cells Identifies Cumulative Expression Patterns of EMT-related Genes in Metastatic Prostate Cancer

gan Chen, Chun-Liang, Mahalingam, Devalingam, Osmulski, Pawel, Jadhav, Rohit R., Wang, Chiou-Miin, Leach, Robin J., Chang, Tien-Cheng, Weitman, Steven D., Kumar, Addanki Pratap, Sun, LuZhe, Gaczynska, Maria E., Thompson, Ian M., Huang, Tim Hui-Ming
Cyhoeddwyd yn Prostate (2012)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

gan Kelly, Kevin R., Friedberg, Jonathan W., Park, Steven I., McDonagh, Kevin, Hayslip, John, Persky, Daniel, Ruan, Jia, Puvvada, Soham, Rosen, Peter, Padmanabhan Iyer, Swaminathan, Stefanovic, Alexandra, Bernstein, Steven H., Weitman, Steven, Karnad, Anand, Monohan, Gregory, VanderWalde, Ari, Mena, Raul, Schmelz, Monika, Spier, Catherine, Groshen, Susan, Venkatakrishnan, Karthik, Zhou, Xiaofei, Sheldon-Waniga, Emily, Leonard, E. Jane, Mahadevan, Daruka
Cyhoeddwyd yn Clin Cancer Res (2018)

Single-cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer

gan Taverna, Josephine A., Hung, Chia-Nung, DeArmond, Daniel T., Chen, Meizhen, Lin, Chun-Lin, Osmulski, Pawel A., Gaczynska, Maria E., Wang, Chiou-Miin, Lucio, Nicholas D., Chou, Chih-Wei, Chen, Chun-Liang, Nazarullah, Alia, Lampkin, Shellye R., Qiu, Lianqun, Bearss, David J., Warner, Steven, Whatcott, Clifford J., Mouritsen, Lars, Wade, Mark, Weitman, Steven, Mesa, Ruben A., Kirma, Nameer B., Chao, Wei-Ting, Huang, Tim H.-M.
Cyhoeddwyd yn Cancer Res (2020)